Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14, 374

Standard

Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14, 374. / Bailey, Simon; André, Nicolas; Gandola, Lorenza; Massimino, Maura; Wheatley, Keith; Gates, Simon; Homer, Victoria; Rutkowski, Stefan; Clifford, Steven C.

In: CANCERS, Vol. 16, No. 6, 1084, 07.03.2024.

Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

Harvard

APA

Bailey, S., André, N., Gandola, L., Massimino, M., Wheatley, K., Gates, S., Homer, V., Rutkowski, S., & Clifford, S. C. (2024). Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14, 374. CANCERS, 16(6), [1084]. https://doi.org/10.3390/cancers16061084

Vancouver

Bibtex

@article{256e5d8432704522984177e9b59eb672,
title = "Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14, 374",
author = "Simon Bailey and Nicolas Andr{\'e} and Lorenza Gandola and Maura Massimino and Keith Wheatley and Simon Gates and Victoria Homer and Stefan Rutkowski and Clifford, {Steven C}",
year = "2024",
month = mar,
day = "7",
doi = "10.3390/cancers16061084",
language = "English",
volume = "16",
journal = "CANCERS",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "6",

}

RIS

TY - JOUR

T1 - Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14, 374

AU - Bailey, Simon

AU - André, Nicolas

AU - Gandola, Lorenza

AU - Massimino, Maura

AU - Wheatley, Keith

AU - Gates, Simon

AU - Homer, Victoria

AU - Rutkowski, Stefan

AU - Clifford, Steven C

PY - 2024/3/7

Y1 - 2024/3/7

U2 - 10.3390/cancers16061084

DO - 10.3390/cancers16061084

M3 - Other (editorial matter etc.)

C2 - 38539574

VL - 16

JO - CANCERS

JF - CANCERS

SN - 2072-6694

IS - 6

M1 - 1084

ER -